Reviews

All Items

A systematic review should be introduced by a general summary of content in the form of an Abstract. Following a short introduction, putting the study into context and defining the aim, reviews will concentrate on the most recent developments in the field. A review should clearly describe the search strategy followed (key words, inclusion, exclusion criteria, search engines, ...). No particular format is required; headings should be used to designate the major divisions of the paper. Metaanalyses should quote the guidelines followed (e.g.: Prisma, Cochrane...). A particular form of review is the narrative review, which has no specified literature research strategy, and does not necessarily include all pertinent literature. [4000 words max, abstract 250 words max, 3/5 tables and/or figures]

  • Antithrombotic therapy in idiopathic infertility

    Fabio Tumminello, Silvia Cardi, Corrado Lodigiani, Maria Elisa Mancuso
    https://doi.org/10.4081/btvb.2024.126
    1844
    PDF: 413

  • Blood platelets, prostaglandins and aspirin: a historical and personal rereading

    Giovanni de Gaetano, Chiara Cerletti
    https://doi.org/10.4081/btvb.2024.121
    1139
    PDF: 193

  • Cancer complicated by thrombosis and thrombocytopenia: still a therapeutic dilemma

    Yishi Tan, Marc Carrier, Nicola Curry, Michael Desborough, Kathryn Musgrave, Marie Scully, Tzu-Fei Wang, Mari Thomas, Simon J. Stanworth
    https://doi.org/10.4081/btvb.2024.115
    542
    PDF: 172

  • Cancer-associated ischemic stroke: current knowledge and future directions

    Ronda Lun, Deborah M. Siegal
    https://doi.org/10.4081/btvb.2024.117
    1615
    PDF: 393

  • Distal deep vein thrombosis: is there a way out of this dark forest?

    Matteo Guarascio, Gerardo Nicola Pititto, Alessia Abenante, Marco Paolo Donadini
    https://doi.org/10.4081/btvb.2024.129
    605
    PDF: 194

  • Endothelial cell dysfunction in cancer: a not-so-innocent bystander

    Betül Ünlü, Neha Joshi, Jamie M. O'Sullivan
    https://doi.org/10.4081/btvb.2024.116
    1094
    PDF: 180

  • Factor XI inhibitors: a new option for the prevention and treatment of cancer-associated thrombosis

    Marcello Di Nisio, Matteo Candeloro, Nicola Potere, Ettore Porreca, Jeffrey I. Weitz
    https://doi.org/10.4081/btvb.2024.118
    631
    PDF: 248

  • From rare to aware: confronting Lemierre syndrome

    Silvia Cardi, Filippo Catalani, Luca Valerio, Stefano Barco
    https://doi.org/10.4081/btvb.2024.147
    1645
    PDF: 330

  • Identifying novel biomarkers using proteomics to predict cancer-associated thrombosis

    Maria J. Fernandez Turizo, Rushad Patell, Jeffrey I. Zwicker
    https://doi.org/10.4081/btvb.2024.120
    611
    PDF: 256

  • Location of metastasis and complications in patients with venous thromboembolism and cancer: a systematic review

    Maria Barca-Hernando, Victor Garcia-Garcia, Luis Jara-Palomares
    https://doi.org/10.4081/btvb.2024.114
    388
    PDF: 131

  • Machine learning in cancer-associated thrombosis: hype or hope in untangling the clot

    Rushad Patell, Jeffrey I. Zwicker, Rohan Singh, Simon Mantha
    https://doi.org/10.4081/btvb.2024.123
    1128
    PDF: 227

  • New drugs, old problems: immune checkpoint inhibitors and cancer-associated thrombosis

    Mehrie H. Patel, Alok A. Khorana
    https://doi.org/10.4081/btvb.2024.113
    396
    PDF: 195

  • Recent advances in classic heparin-induced thrombocytopenia (HIT), autoimmune HIT, spontaneous HIT, and vaccine-induced immune thrombotic thrombocytopenia

    Bianca Clerici, Mariangela Scavone, Gian Marco Podda
    https://doi.org/10.4081/btvb.2024.127
    1787
    PDF: 468

  • Role of platelet autophagy in cardiovascular diseases

    Luca D'Ambrosio, Maurizio Forte, Giacomo Frati, Sebastiano Sciarretta
    https://doi.org/10.4081/btvb.2024.133
    767
    PDF: 197

  • Stroke in women: anticoagulation in a complicated puzzle

    Francesco Marongiu, Elvira Grandone, Silvia Marongiu, Antonella Mameli, Doris Barcellona
    https://doi.org/10.4081/btvb.2024.137
    1019
    PDF: 268

  • The evolving landscape of gene therapy for congenital severe hemophilia: a 2024 state of the art

    Giovanni Di Minno, Gaia Spadarella, Ilenia Lorenza Calcaterra, Giancarlo Castaman, Paolo Simioni, Raimondo De Cristofaro, Cristina Santoro, Flora Peyvandi, Matteo Di Minno
    https://doi.org/10.4081/btvb.2024.144
    767
    PDF: 172
    SUPPLEMENTARY MATERIAL: 83

  • The use of creatine and the development of deep vein thrombosis. A scoping review

    Kartik Akkihal, Thomas Varkey, James Kelbert
    https://doi.org/10.4081/btvb.2024.142
    1827
    PDF: 207
    Supplementary: 85

  • Trends and updates on the epidemiology of cancer-associated thrombosis: a systematic review

    Ang Li, Emily Zhou
    https://doi.org/10.4081/btvb.2024.108
    559
    PDF: 213

  • Venous thromboembolism and mortality in patients with hematological malignancies

    Kristen M. Sanfilippo, Tzu-Fei Wang
    https://doi.org/10.4081/btvb.2024.119
    500
    PDF: 172

  • Venous thromboembolism prophylaxis in orthopedic surgery: a narrative review

    Sarah Gallitto, Thomas C. Varkey, Jacob Lahti
    https://doi.org/10.4081/btvb.2024.131
    857
    PDF: 117

  • Venous thromboembolism treatment in patients with cancer: reflections on an evolving landscape

    Agnes Y.Y. Lee
    https://doi.org/10.4081/btvb.2024.111
    1331
    PDF: 245

  • Welcome to the 12th International Conference on Thrombosis and Hemostasis Issues in Cancer! Oral Communications and Posters

    Anna Falanga, Benjamin Brenner, Alok A. Khorana
    https://doi.org/10.4081/btvb.2024.139
    338
    PDF: 311